Immunic investor relations
Witryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive … WitrynaWednesday, June 16, 2024 10:00 AM EDT. Eyenovia Inc. First Quarter 2024 Earnings Call. Wednesday, May 12, 2024 4:30 PM EDT. Eyenovia Inc. Fourth Quarter 2024 Earnings Call. Thursday, March 25, 2024 4:30 PM EDT. 33rd Annual Roth Conference. Monday, March 15 - Wednesday, March 17, 2024.
Immunic investor relations
Did you know?
Witryna25 kwi 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... Witryna5 sty 2024 · Investor Relations . We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and ... H.C. Wainwright 5th Annual NASH Investor Conference, October 12, 2024. Tuesday, October 12, 2024. 3:30pm - 4:30pm EDT.
Witryna5 sty 2024 · Investor Relations. Investor/Media Home; Press Releases; Events & Presentations; Analyst Coverage; Stock Information; SEC Filings; Corporate Governance; Investors/Media FAQs - Landos - Investor Tools. Print Page; RSS Feeds; Email Alerts; Landos Biopharma, Inc. PO Box 11239 Blacksburg, VA 24062. … Witryna10 lis 2024 · Members of Immunic's management and investor relations teams will attend this virtual conference. To schedule a meeting, please contact an Evercore representative. ... Head of Investor Relations ...
WitrynaImmunic Therapeutics has raised a total of $284.4M in funding over 9 rounds. Their latest funding was raised on Oct 10, 2024 from a Post-IPO Equity round. Immunic Therapeutics is registered under the ticker NASDAQ:IMUX . Immunic Therapeutics is funded by 21 investors. Vivo Capital and RTW Investments are the most recent … Witryna4 paź 2024 · Members of Immunic's business development and investor relations teams will attend this conference in Leipzig, ... Head of Investor Relations and Communications +49 89 2080 477 09
Witryna3 kwi 2024 · Investor Home. Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead …
Witryna25 kwi 2024 · NEW YORK, April 25, 2024 /PRNewswire/ -- Immunic, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic... April 10, 2024 the jam the bitterest pillWitryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected]. US Media ... the jam town called malice release dateWitryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group … the jam trainersWitryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … the jam traductionWitryna6 lip 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... the jam town called malice tabWitrynaSEC Filings. Select the filing type and date range you wish to view from the drop-down menus below. An annual report to security holders. Open An annual report to security holders. in HTML. Open An annual report to security holders. in DOC file. Open An annual report to security holders. in PDF file. the jam tonight at noon lyricsWitryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE … the jam tour 1980